Discovery of MMP activated peptide-doxorubicin prodrugs as anti-tumor agents: Part I

被引：0
作者：
Han, Wei
Jiang, XiangJun
Hu, Zilun
Graciani, Nilsa
Albright, Charles F.
Yue, Eddy
Zhang, Mingzhu
Dowling, Randine
Huang, Pearl
Oliff, Allen
Copeland, Robert A.
Trainor, George L.
Combs, Andrew P.
Seitz, Steven P.
机构：
[1] Bristol Myers Squibb, Pharmaceut Res Inst, Princeton, NJ 08543 USA
[2] GlaxoSmithKline Inc, Stevenage, Herts, England
来源：
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY | 2006年 / 231卷
关键词：
D O I：
暂无
中图分类号：
O6 [化学];
学科分类号：
0703 ;
摘要：
271-MEDI
引用
收藏
页数：2
相关论文
共 50 条
[41]   ENZYME ACTIVATED ANTI-TUMOR AGENTS .4. COMPARATIVE KINETICS OF N,N-P-DI-2-CHLOROETHYLAMINOPHENYL PHOSPHATE HYDROLYSIS CATALYZED BY PHOSPHATASES OF NORMAL AND NEOPLASTIC TISSUES [J].
WORKMAN, P ;
DOUBLE, JA .
BIOCHEMICAL PHARMACOLOGY, 1978, 27 (02) :199-202
[42]   Anti-tumor activity of KRASG12C inhibitors is enhanced when combined with Cdc42 effector p21-activated kinase 4 targeting agents. [J].
Khan, Husain Yar ;
Bannoura, Sahar ;
Mamdani, Hirva ;
Aboukameel, Amro ;
Mzannar, Yousef ;
Li, Yiwei ;
Al-Hallak, Mohammad Najeeb ;
Azar, Ibrahim ;
Kim, Steve ;
Beydoun, Rafic ;
Mohammad, Ramzi ;
Landesman, Yosef ;
Zhang, Yue ;
Baloglu, Erkan ;
Senapedis, William ;
Sukari, Ammar ;
Nagasaka, Misako ;
Shields, Anthony ;
Azmi, Asfar S. .
CANCER RESEARCH, 2022, 82 (12)
[43]   Combined treatment with epigenetic agents enhances anti-tumor activity of MAGE-D4 peptide-specific T cells by upregulating the MAGE-D4 expression in glioma [J].
Bi, Shui-Qing ;
Zhang, Qing-Mei ;
Zeng, Xia ;
Liu, Chang ;
Nong, Wei-Xia ;
Xie, Huan ;
Li, Feng ;
Lin, Li-Na ;
Luo, Bin ;
Ge, Ying-Ying ;
Xie, Xiao-Xun .
FRONTIERS IN ONCOLOGY, 2022, 12
[44]   Antigenic Hsp70-peptide upregulate altered cell surface MHC class I expression in TAMs and increases anti-tumor function in Dalton's lymphoma bearing mice [J].
Gautam, Pramod Kumar ;
Acharya, Arbind .
TUMOR BIOLOGY, 2015, 36 (03) :2023-2032
[45]   Poly (I:C)-DOTAP cationic nanoliposome containing multi-epitope HER2-derived peptide promotes vaccine-elicited anti-tumor immunity in a murine model [J].
Talesh, Ghazal Alipour ;
Ebrahimi, Zahra ;
Badiee, Ali ;
Mansourian, Mercedeh ;
Attar, Hossein ;
Arabi, Leila ;
Jalali, Seyed Amir ;
Jaafari, Mahmoud Reza .
IMMUNOLOGY LETTERS, 2016, 176 :57-64
[46]   ESCMID Study Group for Infections in Compromised Hosts (ESGICH) Consensus Document on the safety of targeted and biological therapies: an infectious diseases perspective (Soluble immune effector molecules [I]: anti-tumor necrosis factor-α agents) [J].
Baddley, J. W. ;
Cantini, F. ;
Goletti, D. ;
Gomez-Reino, J. J. ;
Mylonakis, E. ;
San-Juan, R. ;
Fernandez-Ruiz, M. ;
Torre-Cisneros, J. .
CLINICAL MICROBIOLOGY AND INFECTION, 2018, 24 :S10-S20
[47]   The anti-tumor effects of two novel multivalent/multifunctional agents derived from hR1, a humanized anti-insulin-like growth factor receptor-I monoclonal antibody, are enhanced in renal cell carcinoma and synergistic with an mTOR inhibitor [J].
Cardillo, Thomas M. ;
Nair, Anju ;
Zalath, Maria ;
Arrojo, Roberto ;
Trisal, Preeti ;
Rossi, Edmund A. ;
Goldenberg, David M. ;
Chang, Chien-Hsing .
CANCER RESEARCH, 2012, 72
[48]   A novel anti-angiogenic/anti-metastatic peptide, ATN-161 (Ac-PHSCN-NH2), which targets multiple fully activated integrins including alpha-5 beta-1 and alpha-v beta-3, leads to increased anti-tumor activity and increased survival in multiple tumor models when combined with chemotherapy [J].
Plunkett, ML ;
Tel-Tsur, Z ;
Bera, M ;
Beck, I ;
Avery, J ;
Livant, DL ;
Mazar, AP .
EUROPEAN JOURNAL OF CANCER, 2002, 38 :S79-S79
[49]   Anti-tumor vaccination in advanced malignancy with class I and II htert peptide pulsed dendritic cells (dcs) fails to enhance antigen specific cd8+cytotoxic t cell (ctl) responses and generates regulatory t cells in circulation [J].
Aloysius, Mark ;
Verma, Chandan ;
Robins, Richard ;
Eremin, Jennifer ;
Srinivasan, Thiagarajan ;
Farzaneh, Farzin ;
Hardwick, Nicola ;
Habib, Nagy ;
Mc Kechnie, Alastair ;
Harrison, Phillip ;
El-Sheemy, Mohamad ;
Eremin, Oleg .
CANCER RESEARCH, 2008, 68 (09)
[50]   Discovery of a new class of 16-membered (2Z,11Z)-3,11-di(aryl/naphthyl)-1,13-dioxa-5,9-dithia-2,12-diazacyclohexadeca-2,11-dienes as anti-tumor agents [J].
Bodireddy, Mohan Reddy ;
Mahla, Ranjeet Singh ;
Mohinuddin, P. Md. Khaja ;
Reddy, G. Trivikram ;
Prasad, D. Vijaya Raghava ;
Kumar, Himanshu ;
Reddy, N. C. Gangi .
RSC ADVANCES, 2016, 6 (79) :75651-75663
12345